IMPEL PHARMACEUTICALS INC: cash_and_equivalents

Value{"amount": 60948000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2021-06-30)
Statuscurrent
EntityIMPEL PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-21-001473 · Open the official SEC filing →
Retrieved: 2026-08-19T14:16:28.588953+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001445499/cash-and-equivalents/2021-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/4bead02f-a046-4e2e-847b-c7ae79a06200

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies